The treatment of Boils And Carbuncles & Tinnitus with vitamins

Boils And Carbuncles and Tinnitus: Mitamins custom make quality formulas for the treatment of Boils And Carbuncles & Tinnitus with vitamins. A Boils And Carbuncles & Tinnitus formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Boils and Carbuncles and Tinnitus

  • Amount Per Serving
    % DV
    Vitamin A
    5000
    IU
    100%
    Vitamin C
    500
    mg
    833%
    Vitamin E
    100
    IU
    333%
    Vitamin B6
    50
    mg
    2500%
    Magnesium
    50
    mg
    13%
    Zinc
    30
    mg
    200%
  • Amount Per Serving
    % DV
    Copper
    1
    mg
    50%
    CoQ-10
    20
    mg
    *
    Garlic Extract
    50
    mg
    *
    Ginkgo Extract
    80
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Boils and Carbuncles and Tinnitus
Serving Size:4-5

Boils and Carbuncles and Tinnitus Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
FDA Panel Urges Stronger Warnings for Anemia Drugs (HealthDay)
A U.S. Food and Drug Administration advisory panel on Thursday called for new warnings and additional safety studies on anemia drugs commonly used to treat patients undergoing kidney dialysis or chemotherapy.
Wyeth Pharmaceuticals And Solvay Pharmaceuticals, Inc. Announce Receipt Of An FDA Action Letter For Bifeprunox
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Solvay Pharmaceuticals, Inc. announced today the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical antipsychotic that was reviewed for the acute treatment of schizophrenia, as well as the maintenance of stable adult patients. The Agency stated that the drug was not approvable at this time.
This information concerning the support of Boils and Carbuncles and Tinnitus treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments